Market Summary
USD82.62+1.72
Delayedas of 20 Sep 2023, 03:24 pm2.13%
MED Stock Price
MED RSI Chart
MED Valuation
MED Price/Sales (Trailing)
MED Profitability
MED Fundamentals
MED Revenue
MED Earnings
Price Action
52 Week Range
77.67131.42
(Low)(High)
Last 7 days
-1.3%
Last 30 days
-4.0%
Last 90 days
-4.7%
Trailing 12 Months
-31.1%
MED Financial Health
MED Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for MED
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-13 | MacKenzie Jonathan Barrett | sold (taxes) | -810 | 81.08 | -10.00 | vp, finance & cao |
2023-08-15 | BROWN JEFFREY J | sold | -2,088,780 | 90.1814 | -23,162 | - |
2023-08-14 | BROWN JEFFREY J | sold | -1,403,260 | 92.6 | -15,154 | - |
2023-08-08 | SCHLACKMAN SCOTT | bought | 3,561 | 89.42 | 39.824 | - |
2023-08-08 | BROWN JEFFREY J | bought | 3,947 | 89.42 | 44.141 | - |
2023-08-08 | Hoer Michael A. | bought | 3,366 | 89.42 | 37.644 | - |
2023-08-08 | Thomas Andrea B | bought | 3,408 | 89.42 | 38.115 | - |
2023-08-04 | BROWN JEFFREY J | bought | 62,195 | 100 | 621 | - |
2023-08-04 | BROWN JEFFREY J | bought | 6,713 | 100 | 67.119 | - |
2023-07-20 | Maloney James P. | acquired | - | - | 3,574 | chief financial officer |
Which funds bought or sold MED recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | -219 | 1,751 | -% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | -1,163 | 9,308 | -% |
2023-08-23 | Dean Capital Management | added | 10.1 | -24,094 | 1,110,160 | 1.48% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 35.71 | 239,728 | 1,400,830 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 5.69 | -22,000 | 330,000 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.88 | -205,876 | 1,208,490 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -16.91 | -104,724 | 302,327 | -% |
2023-08-18 | Legato Capital Management LLC | added | 18.31 | 80,329 | 1,632,060 | 0.22% |
2023-08-16 | Bridge City Capital, LLC | added | 41.93 | 307,950 | 1,484,600 | 0.70% |
2023-08-16 | Nuveen Asset Management, LLC | added | 0.57 | -905,282 | 7,634,720 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Medifast
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 13, 2023 | renaissance technologies llc | 5.78% | 632,110 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 15.35% | 1,676,883 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 16.9% | 1,847,773 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 16.9% | 1,847,773 | SC 13G/A | |
| Feb 11, 2022 | renaissance technologies llc | 6.87% | 797,610 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 12.91% | 1,499,306 | SC 13G/A | |
| Jan 27, 2022 | blackrock inc. | 17.2% | 1,995,911 | SC 13G/A | |
| Jan 26, 2022 | blackrock inc. | 17.2% | 1,995,911 | SC 13G/A | |
| Mar 10, 2021 | vanguard group inc | 10.68% | 1,257,265 | SC 13G/A | |
| Feb 16, 2021 | miller value partners, llc | 0.00% | 0 | SC 13G/A |
Recent SEC filings of Medifast
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 15, 2023 | 4 | Insider Trading | |
| Sep 07, 2023 | 8-K | Current Report | |
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 07, 2023 | 10-Q | Quarterly Report |
Peers (Alternatives to Medifast)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
PG | 357.9B | 82.0B | 0.69% | 12.10% | 25.07 | 4.46 | 2.27% | -0.60% |
CL | 63.2B | 18.7B | -1.78% | -3.04% | 35.42 | 3.52 | 5.51% | -22.99% |
EL | 54.4B | 15.9B | -2.99% | -37.10% | 53.87 | 3.42 | -10.30% | -58.06% |
KMB | 48.5B | 20.4B | -3.02% | 1.26% | 24.55 | 2.39 | 1.47% | -8.06% |
CLX | 17.1B | 7.4B | -10.02% | -2.31% | 115.04 | 2.32 | 3.97% | -67.75% |
| MID-CAP | ||||||||
COTY | 9.8B | 5.6B | 1.68% | 46.68% | 19.25 | 1.76 | 4.71% | 95.84% |
ELF | 6.1B | 672.6M | -4.71% | 184.69% | 61.19 | 9.1 | 61.02% | 257.75% |
BRBR | 5.4B | 1.6B | 6.25% | 68.74% | 35.01 | 3.41 | 18.10% | 162.61% |
IPAR | 4.5B | 1.2B | 6.42% | 75.08% | 30.3 | 3.68 | 25.12% | 47.03% |
EPC | 2.0B | 2.3B | 3.74% | 1.21% | 16.74 | 0.87 | 3.51% | 7.43% |
| SMALL-CAP | ||||||||
USNA | 1.2B | 947.8M | -5.86% | -1.13% | 18.15 | 1.21 | -12.16% | -28.99% |
MED | 880.9M | 1.4B | -3.98% | -31.07% | 6.63 | 0.64 | -17.41% | -15.28% |
UG | 35.2M | 10.4M | 1.59% | -37.75% | 15.72 | 3.39 | -27.57% | -39.04% |
Medifast News
Returns for MED
Cumulative Returns on MED
13.9%
10-Year Cumulative Returns
14.2%
7-Year Cumulative Returns
-15.7%
5-Year Cumulative Returns
-21.0%
3-Year Cumulative Returns
Risks for MED
What is the probability of a big loss on MED?
98.8%
Probability that Medifast stock will be more than 20% underwater in next one year
89.6%
Probability that Medifast stock will be more than 30% underwater in next one year.
82.3%
Probability that Medifast stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does MED drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Medifast was unfortunately bought at previous high price.
Drawdowns
Financials for Medifast
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | -10.3% | 1,373 | 1,530 | 1,599 | 1,639 | 1,662 | 1,603 | 1,526 | 1,413 | 1,271 | 1,097 | 935 | 841 | 759 | 726 | 714 | 689 | 638 | 568 | 501 | 433 | 371 |
| Cost Of Revenue | -10.4% | 399 | 445 | 458 | 454 | 453 | 422 | 398 | 365 | 326 | 286 | 237 | 214 | 194 | 179 | 177 | 171 | 156 | 138 | 121 | 103 | 90.00 |
| Gross Profit | -10.2% | 974 | 1,085 | 1,140 | 1,185 | 1,209 | 1,181 | 1,128 | 1,049 | 946 | 811 | 698 | 627 | 566 | 547 | 537 | 518 | 482 | 430 | 380 | 330 | 281 |
| S&GA Expenses | -11.2% | 801 | 901 | 956 | 986 | 1,003 | 963 | 911 | 841 | 749 | 648 | 564 | 512 | 475 | 457 | 446 | 426 | 393 | 351 | 311 | 271 | 229 |
| EBITDA | -100.0% | - | 194 | 195 | 209 | 215 | 226 | 223 | 214 | 202 | 168 | 139 | 125 | 100 | 99.00 | 100 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.13* | 0.12* | 0.13* | 0.13* | 0.14* | 0.15* | 0.15* | 0.16* | 0.15* | 0.15* | 0.15* | 0.13* | 0.14* | 0.14* | - | - | - | - | - | - |
| Earnings Before Taxes | -5.3% | 173 | 182 | 184 | 198 | 206 | 218 | 216 | 207 | 197 | 163 | 134 | 115 | 91.00 | 91.00 | 92.00 | 94.00 | 91.00 | 81.00 | 71.00 | 60.00 | 53.00 |
| EBT Margin | -100.0% | - | 0.12* | 0.12* | 0.12* | 0.12* | 0.14* | 0.14* | 0.15* | 0.15* | 0.15* | 0.14* | 0.14* | 0.12* | 0.13* | 0.13* | - | - | - | - | - | - |
| Net Income | -6.2% | 133 | 142 | 144 | 151 | 157 | 165 | 164 | 158 | 150 | 125 | 103 | 95.00 | 76.00 | 76.00 | 78.00 | 74.00 | 72.00 | 64.00 | 56.00 | 47.00 | 40.00 |
| Net Income Margin | -100.0% | - | 0.09* | 0.09* | 0.09* | 0.09* | 0.10* | 0.11* | 0.11* | 0.12* | 0.11* | 0.11* | 0.11* | 0.10* | 0.10* | 0.11* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 199 | 178 | 116 | 68.00 | 40.00 | 60.00 | 97.00 | 130 | 174 | 139 | 140 | 118 | 72.00 | 74.00 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | -0.9% | 319 | 322 | 316 | 326 | 341 | 421 | 398 | 371 | 364 | 326 | 276 | 261 | 232 | 202 | 195 | 199 | 213 | 210 | 169 | 174 | 156 |
| Current Assets | -0.7% | 229 | 230 | 223 | 230 | 243 | 324 | 307 | 301 | 304 | 282 | 234 | 217 | 191 | 161 | 154 | 158 | 172 | 169 | 146 | 152 | 135 |
| Cash Equivalents | 19.1% | 147 | 124 | 88.00 | 70.00 | 61.00 | 118 | 104 | 155 | 192 | 206 | 164 | 156 | 131 | 91.00 | 77.00 | 81.00 | 96.00 | 102 | 81.00 | 82.00 | 81.00 |
| Inventory | -28.9% | 69.00 | 97.00 | 119 | 145 | 157 | 189 | 180 | 130 | 96.00 | 62.00 | 53.00 | 42.00 | 39.00 | 48.00 | 49.00 | 52.00 | 48.00 | 43.00 | 39.00 | 44.00 | 27.00 |
| Net PPE | -2.8% | 54.00 | 56.00 | 57.00 | 58.00 | 59.00 | 58.00 | 56.00 | 46.00 | 37.00 | 31.00 | 28.00 | 27.00 | 25.00 | 25.00 | 26.00 | 26.00 | 25.00 | 23.00 | 20.00 | 19.00 | 18.00 |
| Liabilities | -11.6% | 133 | 151 | 161 | 176 | 211 | 205 | 196 | 175 | 170 | 152 | 119 | 121 | 115 | 91.00 | 90.00 | 87.00 | 87.00 | 88.00 | 60.00 | 63.00 | 53.00 |
| Current Liabilities | -12.8% | 115 | 132 | 141 | 154 | 188 | 181 | 170 | 161 | 154 | 145 | 111 | 112 | 107 | 82.00 | 79.00 | 78.00 | 76.00 | 77.00 | 60.00 | 63.00 | 53.00 |
| Shareholder's Equity | 8.6% | 186 | 171 | 155 | 151 | 129 | 216 | 202 | 196 | 195 | 175 | 157 | 140 | 117 | 111 | 105 | 111 | 126 | 122 | 109 | 112 | 103 |
| Retained Earnings | 7.9% | 164 | 152 | 140 | 132 | 129 | 203 | 190 | 183 | 185 | 179 | 154 | 140 | 119 | 110 | 169 | 163 | 156 | 143 | 131 | 125 | 117 |
| Additional Paid-In Capital | 13.2% | 22.00 | 19.00 | 22.00 | 19.00 | - | 13.00 | 12.00 | 13.00 | 11.00 | 9.00 | 8.00 | 5.00 | 3.00 | 0.00 | - | 12.00 | 11.00 | 10.00 | 9.00 | 8.00 | 7.00 |
| Shares Outstanding | 0.0% | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -0.3% | 214 | 215 | 195 | 135 | 96.00 | 73.00 | 95.00 | 122 | 147 | 184 | 145 | 145 | 121 | 78.00 | 84.00 | 80.00 | 69.00 | 76.00 | 61.00 | 55.00 | 61.00 |
| Share Based Compensation | -3.7% | 9.00 | 9.00 | 11.00 | 11.00 | 11.00 | 10.00 | 10.00 | 9.00 | 9.00 | 8.00 | 7.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 4.00 |
| Cashflow From Investing | -24.9% | -14.69 | -11.76 | -11.41 | -13.97 | -22.59 | -29.95 | -29.06 | -16.87 | -8.75 | -2.87 | -1.28 | -2.69 | -1.37 | -2.18 | -6.33 | -5.88 | -5.03 | -4.56 | -1.20 | -0.61 | -2.16 |
| Cashflow From Financing | 42.7% | -113 | -197 | -199 | -206 | -204 | -131 | -125 | -107 | -77.29 | -65.62 | -57.14 | -66.54 | -85.41 | -87.25 | -82.32 | -75.68 | -49.23 | -56.10 | -53.33 | -43.01 | -41.23 |
| Dividend Payments | -1.5% | 73.00 | 74.00 | 72.00 | 71.00 | 69.00 | 67.00 | 64.00 | 60.00 | 57.00 | 53.00 | 53.00 | 49.00 | 44.00 | 40.00 | 35.00 | 32.00 | 29.00 | 26.00 | 23.00 | 21.00 | 19.00 |
| Buy Backs | -91.7% | 10.00 | 120 | 126 | 130 | 156 | 58.00 | 56.00 | 46.00 | 20.00 | 10.00 | 5.00 | - | 46.00 | - | 33.00 | 66.00 | 20.00 | - | 30.00 | - | 40.00 |
MED Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue | $ 296,188 | $ 453,333 | $ 645,170 | $ 870,933 |
| Cost of sales | 85,473 | 131,651 | 188,065 | 246,965 |
| Gross profit | 210,715 | 321,682 | 457,105 | 623,968 |
| Selling, general, and administrative | 172,009 | 272,718 | 364,887 | 519,917 |
| Income from operations | 38,706 | 48,964 | 92,218 | 104,051 |
| Other income (expense) | ||||
| Interest income (expense) | 462 | (164) | 281 | (259) |
| Other expense | (51) | (4) | (53) | (20) |
| Total other (expense) income | 411 | (168) | 228 | (279) |
| Income from operations before income taxes | 39,117 | 48,796 | 92,446 | 103,772 |
| Provision for income taxes | 8,837 | 9,683 | 22,198 | 22,878 |
| Net income | $ 30,280 | $ 39,113 | $ 70,248 | $ 80,894 |
| Earnings per share | ||||
| Basic (in usd per share) | $ 2.78 | $ 3.44 | $ 6.46 | $ 7.06 |
| Diluted (in usd per share) | $ 2.77 | $ 3.42 | $ 6.43 | $ 7.01 |
| Weighted average shares outstanding | ||||
| Basic (in shares) | 10,888 | 11,354 | 10,876 | 11,455 |
| Diluted (in shares) | 10,917 | 11,435 | 10,923 | 11,534 |
| Cash dividends declared per share (in usd per share) | $ 1.65 | $ 1.64 | $ 3.30 | $ 3.28 |
MED Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $ 147,405 | $ 87,691 |
| Inventories | 68,896 | 118,856 |
| Prepaid expenses and other current assets | 12,516 | 16,237 |
| Total current assets | 228,817 | 222,784 |
| Property, plant and equipment - net of accumulated depreciation | 54,412 | 57,185 |
| Right-of-use assets | 16,699 | 18,460 |
| Other assets | 14,269 | 12,456 |
| Deferred tax assets | 4,528 | 5,328 |
| TOTAL ASSETS | 318,725 | 316,213 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | 105,188 | 134,690 |
| Income taxes payable | 4,302 | 428 |
| Current lease obligations | 5,405 | 5,776 |
| Total current liabilities | 114,895 | 140,894 |
| Lease obligations, net of current lease obligations | 18,269 | 20,275 |
| Total liabilities | 133,164 | 161,169 |
| Stockholders' Equity | ||
| Common stock, par value $0.001 per share: 20,000 shares authorized; 10,889 and 10,928 issued and 10,889 and 10,873 outstanding at June 30, 2023 and December 31, 2022, respectively | 11 | 11 |
| Additional paid-in capital | 21,542 | 21,555 |
| Accumulated other comprehensive income | 123 | 24 |
| Retained earnings | 163,885 | 139,852 |
| Less: treasury stock at cost, 0 and 54 shares at June 30, 2023 and December 31, 2022, respectively | 0 | (6,398) |
| Total stockholders' equity | 185,561 | 155,044 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 318,725 | $ 316,213 |
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.